David C. Oxley
Directeur/Bestuurslid bij TB Biosciences, Inc.
Actieve functies van David C. Oxley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
TB Biosciences, Inc.
 TB Biosciences, Inc. Medical/Nursing ServicesHealth Services TB Biosciences, Inc. operates as a early stage development medical diagnostics company which develops a rapid point-of-care tuberculosis tests. It uses key peptides to detect antibodies in patients with active tuberculosis derived from the genome of the tuberculosis organism, thus offering a completely new approach to testing. The firm is using an array of patented peptides developed and exclusively licensed from the New York university school of medicine. The company was founded by Daniel Malamud, Susan Zolla-Pazner, Suman Laal, R. Sam Niedbala and William Abrams in May 2013 and is headquartered in Bethlehem, PA. | Directeur/Bestuurslid | 01-08-2013 | - |
Loopbaan van David C. Oxley
Eerdere bekende functies van David C. Oxley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EXOPHARM | President | 01-08-2021 | 01-01-2023 |
| TRINITY BIOTECH PLC | Verkoop & Marketing | - | - |
| PLUS THERAPEUTICS, INC. | Verkoop & Marketing | 21-05-2010 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Ierland | 2 |
| Australië | 2 |
Operationeel
| Sales & Marketing | 2 |
| Director/Board Member | 1 |
| President | 1 |
Sectoraal
| Health Technology | 4 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| TRINITY BIOTECH PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
TB Biosciences, Inc.
TB Biosciences, Inc. Medical/Nursing ServicesHealth Services TB Biosciences, Inc. operates as a early stage development medical diagnostics company which develops a rapid point-of-care tuberculosis tests. It uses key peptides to detect antibodies in patients with active tuberculosis derived from the genome of the tuberculosis organism, thus offering a completely new approach to testing. The firm is using an array of patented peptides developed and exclusively licensed from the New York university school of medicine. The company was founded by Daniel Malamud, Susan Zolla-Pazner, Suman Laal, R. Sam Niedbala and William Abrams in May 2013 and is headquartered in Bethlehem, PA. | Health Services |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
- Beurs
- Insiders
- David C. Oxley
- Ervaring
